Author: NSV
Your Top Three Cloud Security Resolutions for 2018
With 2017 behind us, it’s time to prepare your IT strategy and goals for the new year. There is a good chance that, if you aren’t using the cloud already, there’s a cloud services migration in store for your organization this year. No matter where you are on your cloud
Read MorePublic safety a driver in DAS deployments
In addition to support for mission critical communications, DAS creates long-term value for commercial real estate owners. Public safety is a major priority in telecommunications and government sectors right now. All 50 states recently opted-in to AT&T’s FirstNet, a $40 billion, nationwide LTE network dedicated to first responders, and major
Read MoreProterixBio, Inc. presenting at Biotech Showcase™ 2018
ProterixBio, Inc. will be attending Biotech Showcase™ 2018, to be held January 8-10th at the Hilton San Francisco Union Square. Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors
Read More8 Reasons You Need Object Storage in 2018
2017 is in the books and 2018 is already upon us. Data storage challenges are escalating faster than ever for many organizations, especially those involved in storing, developing and delivering digital assets. Last year, I wrote about the 7 Reasons You Need Object Storage in 2017 from the perspective of
Read MoreNorman C. Selby
Norman serves on the board of directors of Infinity Pharmaceuticals, Inc., Merz GmbH & Co. KGaA, Metamark Genetics, Inc., National Parks Conservation Association, Ralph Lauren Center, Ulthera, Inc., Memorial Sloan-Kettering Cancer Center and Central Park Conservancy, Inc. Norman was previously a Senior Advisor with Perseus LLC, Chairman of Windhover Information,
Read MoreWillam Sandborn, M.D.
Dr. Sandborn serves as the Chief of Division of Gastroenterology at University of California San Diego Inflammatory Bowel Disease Center and Professor of Clinical Medicine. He served as Chief of the Division of Gastroenterology for the UC San Diego Health System. Dr. Sandborn has served as head of the Division
Read MoreCountdown: 17 Object Storage Hits of 2017
2017 is winding down fast, and we have seen many changes in the object storage landscape over the past year. From conversations we have had with many of you at shows like NAB and SC17, we’ve learned that there is now a much broader understanding of object storage and the
Read MoreThe Stakes for Protecting Personally Identifiable Information Will Be Higher in 2018
While it’s tough to predict what the most significant single threat of 2018 will be, it’s safe to say that 2017 was certainly a wake-up call for both businesses and consumers when it comes to data breaches. From the rampant misconfiguration of Amazon S3 data buckets to stolen email credentials,
Read MoreDisney Acquires Fox; Does Your Wallet Have Room for More VOD?
Unless you have been hiding under a rock (or even if you were), you heard this week that Disney acquired 21st Century Fox. A great summary of the benefits is summarized in Jeff Berman’s blog Analyst: Disney to Benefit from Scale of Fox Transaction. Historically, analysts would have listed content
Read MoreThe 7 Personality Types Needed For The Internet of Things
Fuzzy Logix Aashu Virmani offers his thoughts on what personality traits the people working in IoT will exhibit The post The 7 Personality Types Needed For The Internet of Things appeared first on Fuzzy Logix.
Read MoreWelcome JB&A Distribution to the Caringo Family
I look forward to “Black Friday” every year. It’s not the great shopping deals, the tasty Thanksgiving leftovers or even the “holiday season.” It’s about spending time with my family. Five years ago, we started a tradition on the day after Thanksgiving: we stay in our pajamas, pile on the
Read MoreNorthSea Therapeutics secures €25 million funding for clinical development of promising NASH drug
Lead drug icosabutate, in-licensed from Pronova BioPharma AS Phase IIb-ready at the end of 2018 Naarden, The Netherlands, 12 December 2017 – NorthSea Therapeutics B.V. (‘NST’), a newly established Dutch biotech company, announced today the completion of a €25m Series A funding for the development of icosabutate, a structurally engineered
Read More